journal article·2015-03-24

Elasticity of Nanoparticles Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting

Aaron C. Anselmo, Mengwen Zhang, Sunny Kumar, Douglas R. Vogus, Stefano Menegatti, Matthew E. Helgeson, Samir Mitragotri

ACS Nano· Volume 9· Issue 3
Publisher page

Abstract

The impact of physical and chemical modifications of nanoparticles on their biological function has been systemically investigated and exploited to improve their circulation and targeting. However, the impact of nanoparticles' flexibility (i.e., elastic modulus) on their function has been explored to a far lesser extent, and the potential benefits of tuning nanoparticle elasticity are not clear. Here, we describe a method to synthesize polyethylene glycol (PEG)-based hydrogel nanoparticles of uniform size (200 nm) with elastic moduli ranging from 0.255 to 3000 kPa. These particles are used to investigate the role of particle elasticity on key functions including blood circulation time, biodistribution, antibody-mediated targeting, endocytosis, and phagocytosis. Our results demonstrate that softer nanoparticles (10 kPa) offer enhanced circulation and subsequently enhanced targeting compared to harder nanoparticles (3000 kPa) in vivo. Furthermore, in vitro experiments show that softer nanoparticles exhibit significantly reduced cellular uptake in immune cells (J774 macrophages), endothelial cells (bEnd.3), and cancer cells (4T1). Tuning nanoparticle elasticity potentially offers a method to improve the biological fate of nanoparticles by offering enhanced circulation, reduced immune system uptake, and improved targeting.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Cellular Mechanics and Interactions · Phagocytosis and Immune Regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, Center for Bioengineering, University of California, Santa Barbara, California 93106, United States

Funding

University of California, Santa Barbara · Defense Threat Reduction Agency · Division of Graduate Education

References (45)

Show source-provided references
1. Mitragotri S. · Nat. Mater. · 2009 · 8 · 1510.1038/nmat2344 ↗
2. Mitragotri S. · Adv. Mater. · 2012 · 24 · 371710.1002/adma.201202080 ↗
3. Slack J. D. · J. Pharm. Sci. · 1981 · 70 · 66010.1002/jps.2600700621 ↗
4. Decuzzi P. · J. Controlled Release · 2010 · 141 · 32010.1016/j.jconrel.2009.10.014 ↗
5. Moghimi S. M. · FASEB J. · 2005 · 19 · 31110.1096/fj.04-2747rev ↗
6. Jain R. K. · Annu. Rev. Biomed. Eng. · 1999 · 1 · 24110.1146/annurev.bioeng.1.1.241 ↗
7. Choi H. S. · Nat. Biotechnol. · 2007 · 25 · 116510.1038/nbt1340 ↗
8. Couvreur P. · Adv. Drug Delivery Rev. · 2013 · 65 · 2110.1016/j.addr.2012.04.010 ↗
9. Champion J. A. · J. Controlled Release · 2007 · 121 · 310.1016/j.jconrel.2007.03.022 ↗
10. Tao L. · Exp. Biol. Med. · 2011 · 236 · 2010.1258/ebm.2010.010243 ↗
11. Muro S. · Mol. Ther. · 2008 · 16 · 145010.1038/mt.2008.127 ↗
12. Anselmo A. C. · ACS Nano · 2014 · 8 · 1124310.1021/nn503732m ↗
13. Geng Y. · Nat. Nanotechnol. · 2007 · 2 · 24910.1038/nnano.2007.70 ↗
14. Kolhar P. · Proc. Natl. Acad. Sci. U.S.A. · 2013 · 110 · 1075310.1073/pnas.1308345110 ↗
15. Decuzzi P. · Biomaterials · 2006 · 27 · 530710.1016/j.biomaterials.2006.05.024 ↗
16. Gratton S. E. · Proc. Natl. Acad. Sci. U.S.A. · 2008 · 105 · 1161310.1073/pnas.0801763105 ↗
17. Champion J. A. · Pharm. Res. · 2009 · 26 · 24410.1007/s11095-008-9626-z ↗
18. Champion J. A. · Proc. Natl. Acad. Sci. U.S.A. · 2006 · 103 · 493010.1073/pnas.0600997103 ↗
19. Gilbert J. B. · Adv. Mater. · 2013 · 25 · 594810.1002/adma.201302673 ↗
20. Discher D. E. · Science · 2009 · 324 · 167310.1126/science.1171643 ↗
21. Geiger B. · Nat. Rev. Mol. Cell Biol. · 2009 · 10 · 2110.1038/nrm2593 ↗
22. Vogel V. · Curr. Opin. Cell Biol. · 2009 · 21 · 3810.1016/j.ceb.2009.01.002 ↗
23. Engler A. J. · Cell · 2006 · 126 · 67710.1016/j.cell.2006.06.044 ↗
24. Discher D. E. · Science · 2005 · 310 · 113910.1126/science.1116995 ↗
25. Griffin M. A. · J. Cell Sci. · 2004 · 117 · 585510.1242/jcs.01496 ↗
26. Kong H. J. · Nat. Mater. · 2005 · 4 · 46010.1038/nmat1392 ↗
27. Merkel T. J. · Proc. Natl. Acad. Sci. U.S.A. · 2011 · 108 · 58610.1073/pnas.1010013108 ↗
28. Merkel T. J. · J. Controlled Release · 2012 · 162 · 3710.1016/j.jconrel.2012.06.009 ↗
29. Haghgooie R. · Macromol. Rapid Commun. · 2010 · 31 · 12810.1002/marc.200900302 ↗
30. Anton N. · J. Controlled Release · 2008 · 128 · 18510.1016/j.jconrel.2008.02.007 ↗
31. Landfester K. · 2011 · 39
32. Steinhilber D. · Biomaterials · 2011 · 32 · 131110.1016/j.biomaterials.2010.10.010 ↗
33. Hamidi M. · Adv. Drug Delivery Rev. · 2008 · 60 · 163810.1016/j.addr.2008.08.002 ↗
34. Anselmo A. C. · ACS Nano · 2013 · 7 · 1112910.1021/nn404853z ↗
35. Howard M. · ACS Nano · 2014 · 8 · 410010.1021/nn500136z ↗
36. Hayes S. H. · Int. J. Clin. Exp. Pathol. · 2009 · 2 · 553
37. duPre S. A. · Exp. Mol. Pathol. · 2008 · 85 · 17410.1016/j.yexmp.2008.05.002 ↗
38. Lawson C. · Pharmacol. Rep. · 2009 · 61 · 2210.1016/S1734-1140(09)70004-0 ↗
39. Sikorski E. · J. Immunol. · 1993 · 151 · 523910.4049/jimmunol.151.10.5239 ↗
40. Scott G. S. · J. Neuroimmunol. · 2004 · 155 · 3210.1016/j.jneuroim.2004.05.011 ↗
41. Ravetch J. V. · Annu. Rev. Immunol. · 2001 · 19 · 27510.1146/annurev.immunol.19.1.275 ↗
42. Moghimi S. M. · Pharmacol. Rev. · 2001 · 53 · 28310.1016/S0031-6997(24)01494-7 ↗
43. Owens D. E. · Int. J. Pharm. · 2006 · 307 · 9310.1016/j.ijpharm.2005.10.010 ↗
44. Dhillon S. · 2006 · 1
45. Herant M. · J. Cell Sci. · 2005 · 118 · 178910.1242/jcs.02275 ↗